OrphanDrug
OrphanDrug
Pharma Knowledge Base

infantile myofibromatosis

MeSH: D018224ORPHA: 2591

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

connective tissue benign neoplasm that is characterized by the development of benign tumors in the skin, striated muscles, bones, and in exceptional cases, visceral organs

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with infantile myofibromatosis, sourced from HPO and Orphanet clinical annotations.

Abnormality of the kidneyGingival fibromatosisAbnormality of the faceAbnormality of the eyeAbnormal thorax morphologyAbnormal skull morphologyChondrocalcinosisAbnormal metaphysis morphologyLimitation of joint mobilitySubcutaneous noduleAbnormal hair morphologyAbnormal intestine morphologyTracheoesophageal fistulaOsteolysisNeoplasm of the pancreasAbnormality of the musculatureHypercalcemiaHemiplegia/hemiparesisAbnormal sacrum morphologyIntestinal obstructionIrregular hyperpigmentationNeoplasm of the skinFibromaBone cystSarcomaNeoplasm of the lungBenign neoplasm of the central nervous systemSkin ulcer

Classification & Codes

MeSH Code

D018224

Orphanet Code

ORPHA:2591
infantile myofibromatosis
MeSHD018224
OrphanetORPHA:2591
Treatments0 drug(s)
Symptoms on record28 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO